Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 242.50 45,417 08:00:00
Bid Price Offer Price High Price Low Price Open Price
235.00 250.00 242.50 242.50 242.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 74.58 15.25 17.60 13.8 164
Last Trade Time Trade Type Trade Size Trade Price Currency
17:03:23 O 95 245.063 GBX

Eco Animal Health (EAH) Latest News

More Eco Animal Health News
Eco Animal Health Investors    Eco Animal Health Takeover Rumours

Eco Animal Health (EAH) Discussions and Chat

Eco Animal Health Forums and Chat

Date Time Title Posts
23/10/202019:17Eco Animal Health Group: Early dewormer gets OK1,173

Add a New Thread

Eco Animal Health (EAH) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Eco Animal Health trades in real-time

Eco Animal Health (EAH) Top Chat Posts

Eco Animal Health Daily Update: Eco Animal Health Group Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker EAH. The last closing price for Eco Animal Health was 242.50p.
Eco Animal Health Group Plc has a 4 week average price of 201.50p and a 12 week average price of 201.50p.
The 1 year high share price is 357p while the 1 year low share price is currently 125p.
There are currently 67,517,126 shares in issue and the average daily traded volume is 662,063 shares. The market capitalisation of Eco Animal Health Group Plc is £163,729,030.55.
hatfullofsky: A current year trading update will be provided after the half year ending on 30 September 2020.Come on EAH get a wiggle on !
1aconic: Yeah, the websites are awful! I just assume that most selling is through distribution channels and not so much ad hoc direct customer chasing - from what I can gather that's the case with a lot of vetinary medicines but not entirely sure over everything EAH does. There was another big round of selling (an almost identical 725,000 equating to over 1%) in late Sept. My thinking on that is one of the institutions is reducing because of the Germany ASF outbreak. Think it might be just part on an institution being cautious and don't want to be caught by a major problem they have to explain to investment boards and fund holders. They'd rather sell now and buy later at a much higher price when it's de-risked (e.g. a vaccine announced) a bit rather than be caught with their pants down. I personally think it's a little short sighted as EAH seems to be holding up well in terms of revenue despite it's main market already having been absolutely decimated. Would be interested to hear other people's views on that too.
1aconic: Took another long look here this week. Definitely still some risks - the latest outbreak of ASF in Germany illustrates that and the US/China trade tensions are still a background concern. But there are plenty of postives too: a potential ASF vaccine reported not long ago; from the trading update EAH's own revenues will be above last year thanks to improved margins and taking competitor market share(unless I'm missing something that's a pretty impressive performance under the conditions?); new reports this week that China has almost exhausted its frozen pork stockpiles and prices are soaring; EAH potentially has some new developments coming out of the R&D dept on which specific updates may not be too far away; etc, etc. I personally think there's still plenty to be positive about in the medium term and calculate that the risk has been priced in far more than the potential. I've doubled up my holding after the price pulled back a bit this week. GLA.
cerrito: Thought of EAH this morning reading a story in the FT on the food situation. Pork prices up 86% in July compared to a year earlier which would be good news for EAH. Not so good news was major flooding in Sichuan province-China's top pork producer.
grupo: EAH Peel Hunt Buy 430.00 - Reiterates
cerrito: For those who may have missed it an extract from the AGM statement of ANP a few days ago with the following encouraging news for EAH, quote Encouragingly, sales in China are now showing signs of recovery as farmers are re-stocking their pig operations following the African Swine Fever epidemic and also a ban on the use of anti-biotic growth promoters (AGPs) in animal feed is expected to come into force in July. unquote
cerrito: For me an unexpected piece of good news this morning and very pleased to read that they had a strong April and May. My concerns about lockdowns in China and indeed continuing presence of the ASF disease there as well as disruptions in the US pork markets with what is going on in the slaughter houses have been misplaced. Also note that in China and USA they had a good H2 in FY18/19. I have to say somewhat surprised that no dividend but good to be reminded that a comfortable majority of the cash is not held by 100% owned affiliates. One assumes that their China business does not get caught up in any UK/China backlash if for no other reason that an efficient pork market is of key strategic importance to the Chinese authorities. The frustrating thing-at least for me- is that we are given no indication of their understanding of market expectations for 2020. I have asked the FD for clarity on this. Any of you have a handle on this? FWIW Digital Look has forecast 19/20 revenues of £64.27m and pre tax profit of £5.16m. They have no forecast for EBITDA. Note that restated 18/19 had revenue of £67.2m and pretax profit of £10m so that in terms of pre tax profit any increase of market forecast was not a big ask. I have misread this share but if this good news continues the price could get to my break even of £3.It is great that they are not resting on their laurels and are continuing to do R&D; that said it was unclear to me if the reduction in spend this current half year was because they are conserving cash or the natural R&D expenditure cycle. While big picture there are very clearly strategically in a very sweet spot, I do fret that their business is full of trip wires and one wonders where and when ASF will reemerge.
cerrito: Re the Friday RNS, given that the EMA has signed off on these for poultry products, I have no idea how significant it is what the EMA are doing with pork; that said good news. Over recent weeks has been pretty quiet on the ASF front, except that it has got to India where EAH do not appear to have much activity. Perhaps reflects the world cannot focus on both Covid and ASF. No idea if EAH working on a vaccine for ASF or even if one is feasible. However would have thought this was for a company with deeper pockets than EAH, Went onto the corporate and commercial website to see if there was any news, but just silence.
cerrito: I agree that very tacky for any company to put out the interim results on the last possible day-even more when that is New Year eve. The company would say that the results are in line with the Nov 11 trading statement and they needed the maximum time to bed down all the accounting adjustments, which suggest that they were time consuming and quite extensive. I do not see myself buying more-I have messed up here at least in the short term and have more than is good for me. Nor do I see myself selling. This is a candidate for a takeover especially at the current FX rate. They have done well ex China and the US and they are right to say that there will continue to be maximum political focus in China to get pork prices down-no doubt by a combination of increased imports and domestic production. I do ask myself how long it will take to reverse their price discounting in the US and continue to fret as to what would happen if ASF reaches the Americas.I recognize the receivables risk in China. I am mystified as to the dividend suspension. I can well understand why they did suspend but am not sure if they have thought through the message that people will pick up. I know nothing about the Chairman and hope that he has both the leadership skills and decisiveness including ing if necessary to replace the CEO. I do not see the share price getting to 460p any time soon and will in the near term meander in a 185//220 zone. I need to go through the figures closely.
cerrito: I can understand why you did what you did Mach100, although my reading of the latest news items is that Japan does not have ASF but does have classical swine virus. That said I am not buying more and if it does make its way to the Americas I hesitate to think what will happen to the share price. Still perplexed that ANP share price is unmoved by all of this.
Eco Animal Health share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201024 18:54:30